Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spero Therapeutics, Inc. | 63,581 | reported | 01 Feb 2022 | tx 14+372,743−32,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Feb 2022 | GRANT_AWARD | Spero Therapeutics, Inc. | 38,014 | 0.00 USD | |
| 01 Feb 2022 | GRANT_AWARD | Spero Therapeutics, Inc. | 53,190 | 0.00 USD | deriv |
| 26 Aug 2021 | GRANT_AWARD | Spero Therapeutics, Inc. | 24,067 | 0.00 USD | |
| 01 Feb 2021 | GRANT_AWARD | Spero Therapeutics, Inc. | 57,432 | 0.00 USD | deriv |
| 16 Dec 2020 | EXERCISE | Spero Therapeutics, Inc. | 12,000 | 5.90 USD | |
| 16 Dec 2020 | SALE | Spero Therapeutics, Inc. | 12,000 | 19.00 USD | |
| 16 Dec 2020 | EXERCISE | Spero Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 03 Feb 2020 | GRANT_AWARD | Spero Therapeutics, Inc. | 55,000 | 0.00 USD | deriv |
| 02 Jan 2019 | GRANT_AWARD | Spero Therapeutics, Inc. | 65,000 | 0.00 USD | deriv |
| 05 Jul 2018 | EXERCISE | Spero Therapeutics, Inc. | 4,000 | 5.90 USD | |
| 05 Jul 2018 | SALE | Spero Therapeutics, Inc. | 4,000 | 17.50 USD | |
| 05 Jul 2018 | EXERCISE | Spero Therapeutics, Inc. | 4,000 | 0.00 USD | deriv |
| 13 Dec 2017 | GRANT_AWARD | Spero Therapeutics, Inc. | 62,540 | 0.00 USD | deriv |
| 06 Nov 2017 | PURCHASE | Spero Therapeutics, Inc. | 1,500 | 14.00 USD |